ANIK Share Price

Open 43.79 Change Price %
High 44.37 1 Day 0.34 0.78
Low 43.52 1 Week -0.98 -2.18
Close 43.99 1 Month -2.93 -6.24
Volume 57407 1 Year 9.12 26.15
52 Week High 54.96
52 Week Low 34.19
ANIK Important Levels
Resistance 2 44.78
Resistance 1 44.45
Pivot 43.96
Support 1 43.53
Support 2 43.20
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
SIRI 4.18 0.72%
BBEP 0.12 0.00%
MSFT 61.00 2.25%
MSFT 61.00 2.25%
MSFT 61.00 2.25%
GTAT 0.44 0.00%
NASDAQ USA Top Gainers Stocks
CPSL 0.20 122.22%
UNIS 2.93 67.43%
HAUP 0.05 66.67%
LOCM 0.09 50.00%
SCHS 0.12 33.33%
SPIR 0.04 33.33%
MBVT 43.10 31.20%
WRES 0.09 28.57%
KOOL 3.90 27.04%
QKLS 0.19 26.67%
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
QTWW 0.08 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%

Anika Therapeutics Inc. (NASDAQ: ANIK)

ANIK Technical Analysis 4
As on 24th Oct 2016 ANIK Share Price closed @ 43.99 and we RECOMMEND Sell for LONG-TERM with Stoploss of 45.06 & Strong Sell for SHORT-TERM with Stoploss of 47.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
ANIK Target for October
1st Target up-side 49.89
2nd Target up-side 51.33
3rd Target up-side 52.76
1st Target down-side 45.81
2nd Target down-side 44.37
3rd Target down-side 42.94
ANIK Other Details
Segment EQ
Market Capital 156245312.00
Sector Healthcare
Industry Biotechnology
Offical website
ANIK Address
32 Wiggins Avenue
Bedford, MA 01730
United States
Phone: 781-457-9000
Fax: 781-305-9720
Interactive Technical Analysis Chart Anika Therapeutics Inc. ( ANIK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Anika Therapeutics Inc.
ANIK Business Profile
Anika Therapeutics, Inc. (Anika), incorporated in 1992, develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. As of December 31, 2011, Anika’s wholly owned subsidiary, Anika Therapeutics S.r.l., had over 20 products commercialized, primarily in Europe. These products are also all made from hyaluronic acid, based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. The Company’s orthobiologics products consist of joint health and orthopedic products. These products are used in a range of treatments from providing relief from the pain of osteoarthritis, to regenerating damaged tissue, such as cartilage defects. Its joint health products include ORTHOVISC, ORTHOVISC mini, and MONOVISC. ORTHOVISC is available in the United States, Canada, Turkey and other international markets for the treatment of osteoarthritis of the knee, and in Europe for the treatment of osteoarthritis in all joints. ORTHOVISC mini is available in Europe, and is designed for the treatment of osteoarthritis in small joints. MONOVISC is its single injection osteoarthritis treatment indicated for all joints in Europe, and for the knee in Turkey and Canada. ORTHOVISC mini and MONOVISC are the Company’s two joint health products. In the United States, ORTHOVISC is indicated for the treatment of pain caused by osteoarthritis of the knee in patients, who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics, such as acetaminophen. It is a sterile, clear, viscoelastic solution of hyaluronan dissolved in physiological saline, and dispensed in a single-use syringe. The Company has a number of distribution relationships servicing international markets, including Canada, Europe, Turkey, the Middle East, Latin America, and Asia. It offers a number of additional products used in connection with orthopedic regenerative medicine. The products available in Europe include Hyalograft C Autograft for cartilage regeneration; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells; Hyalonect, a woven gauze used as a graft wrap; and Hyaloss, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration. Anika S.r.l. also offers Hyaloglide, an ACP gel used in tenolysis treatment, but with potential for flexor tendon adhesion prevention, and in the shoulder for adhesive capsulitis with additional clinical data. Anika S.r.l.’s products are commercialized through a network of distributors, primarily in Europe, the Middle East, and Korea.